Table 1. Valency of GBPs analyzed with the glycan array.
Category | GBP | Valency | 2° Ab | 3° Ab | Final |
---|---|---|---|---|---|
Plant lectin | Con A-FITC | 4 | 4 | ||
Plant lectin | ECA-FITC | 2 | 2 | ||
Human C type | DC-SIGN-Fc* | 2 | 2 | ||
Human siglec | CD22-Fc | 2 | α-hIgG-F | α-gIgG-F | 8 |
Human galectin | Galectin-4-AF488 | 2 | 2 | ||
Human IgG | Anti-CD15-FITC | 2 | 2 | ||
Human IgG | 2G12 | 2 | α-hIgG-AF | 4 | |
Human IgG/A/M | Serum† | 2 | 2 | ||
Bacterial GBP | Cyanovirin‡ | 2 | 2 | ||
Viral GBP | Influenza HA (H3) | 3 | α-HA-AF | α-mIgG-AF | 12 |
Intact virus | Influenza (PR8)§ | 500 | α-PR8 | α-rIgG-AF | 500 |
Ab, antibody; F, FITC; AF, Alexa Fluor 488; HA, hemagglutinin.
After binding of DC-SIGN, binding was detected by overlay with anti-human IgG-AF488.
After binding of serum diluted 1:25 with PBS, binding was detected by overlay with goat anti-human IgG/M/A-Biotin (1:100) (Pierce) followed by streptavidin-FITC (1:100).
After binding of CVN, binding was detected by overlay with polyclonal rabbit anti-CVN IgG-AF488 followed by anti-rabbit-IgG-FITC.
After binding of virus, binding was detected by overlay with rabbit anti-PR8 followed by goat anti-rabbit-IgG-AF488.